Trials / Completed
CompletedNCT00227188
Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.
Effectiveness of Prevnar in the Prevention on IPD in the Paediatric Population in Spain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 408 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the postlicensure effectiveness of Prevnar in the prevention of IPD in the Spanish paediatric population (children younger than 5 years)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pneumococcal 7-valent conjugate vaccine Prevnar |
Timeline
- Start date
- 2003-05-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2005-09-27
- Last updated
- 2012-11-29
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00227188. Inclusion in this directory is not an endorsement.